
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Gelteq (NASDAQ:GELS) through any online brokerage.
Other companies in Gelteq’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Gelteq to provide a consensus price target.
The stock price for Gelteq (NASDAQ: GELS) is $0.5325 last updated October 8, 2026 at 8:23 AM EDT.
There are no upcoming dividends for Gelteq.
Gelteq does not have any upcoming earnings scheduled.
There is no upcoming split for Gelteq.
Gelteq is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and...